CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Aucta Pharms

For profitWebsite ↗

Also known as: AUCTA | Aucta Pharmaceuticals, Inc | AUCTA PHARMS

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Apr 12, 2017

First marketed drug

Jun 21, 2018

Last known activity

Apr 9, 2026

Timeline

2010s

  1. Jan 1, 2013

    Aucta Pharms— Founded

2020s

  1. Aug 26, 2022

    mexiletine— Marketing Organization

  2. May 4, 2023

    lacosamide— NDA Secondary Org

Drugs by trial phase (2 distinct, 2 trials)

Phase 2 (1 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (8)

Recent trials (3)

Details

Founded
North Brunswick, NJ, US Jan 1, 2013
Last known activity
Apr 9, 2026